U.S. Markets open in 16 hrs, 25 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 7.70 09:30 AM EST | |
|---|---|---|
| Day High | 8.1899 09:54 AM EST |
|
| Range | 0.49 |
| Volume | 2.35 M | |
|---|---|---|
| 30-Day Avg Vol | 857,000 |
|
| Difference | 175.26% |
| Market Cap | 277.24 M | |
|---|---|---|
| Mkt Cap Chg | 3.12 M |
| Shares Out | 34.74 M | |
|---|---|---|
| % Shrs Traded | 6.79% | |
| 1yr EPS Est | -1.27 |
| 52-Wk Low | 1.05 | |
|---|---|---|
| 52-Wk High | 9.14 |
|
| Range | 8.09 |
| Prev Close | 7.89 11/5/09 | |
|---|---|---|
| Today's Open | 7.94 | |
| Change | 0.63% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 2.93 M |
| Revenue (LFY) | 0 | |
|---|---|---|
| Earnings (LFY) | -48.56 M | |
| Earnings (MRQ) | -9.88 M | |
| Next Earn Est | -0.257 | |
| Next Earnings | 03/15/2010 |
|
| EPS (TTM) | -1.36 | |
| 1yr EPS Growth | 6.62% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -6.00 | |
| PEG Ratio | — | |
| Return on Equity | -77.35 | |
| Beta | 1.57 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Poniard Pharmaceuticals is taking a stab at developing better cancer therapies. After abandoning its radiopharmaceuticals research, the firm is now focused on picoplatin, an injectable chemotherapy that ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.257 3/15/10 | — — |
—
—
|
| Last Quarter | -0.293 9/30/09 | -0.29 9/30/09 |
0.003
Beat
|
| 2 Quarters Ago | -0.343 6/30/09 | -0.28 6/30/09 |
0.063
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Gross Profit | -4.58 M | -36.32 M |
| Operating Income | -9.20 M | -49.16 M |
| Net Income | -9.88 M | -48.56 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts